The Challenges of Treating Type 1 Diabetes
Type 1 diabetes is a relentless disease, according to David Maahs, M.D., M.A., Ph.D., from Stanford University.
In theory, type 1 diabetes should be simple to treat, according to David Maahs, M.D., M.A., Ph.D., from Stanford University.
Type 1 diabetes is caused by the body’s inability to make insulin and therefore is a chronic disease that needs everyday treatment.
“It's very simple what we need to do,” Maahs said. “We just need to replace insulin in the way your body should make it but can't make it. The challenge is, it's really hard to do that.”
The key to type 1 diabetes management is always knowing the blood glucose levels, which historically was checked through blood samples taken from the fingers, usually six to 10 times a day.
Earlier this year, Maahs and his colleagues reported findings from a pragmatic, real-world study of a comprehensive approach of managing type1 diabetes in Nature Medicine. They enrolled 133 young (median age 11) people in the Teamwork, Targets, Technology and Tight Control — 4T, for short — study. At 12 months after enrollment, the participants had an average HbA1c of 6.58% and average glucose monitoring indicator of 7.11%. Close to two-thirds (64%) meet the target HbA1c target of 7%. The study participants had an average “time in range” of 68%, which means their blood sugar levels were in the desired range 68% of the time.
Maahs is currently a pediatric endocrinology professor at Stanford University and the Associate Chair for Academic Affairs in Pediatrics at Stanford University and the Lucile Packard Children’s Hospital.
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
The Benefits of 'Hands-on' Coaching for Type 1 Diabetes
March 4th 2025In this part 2 video series, Arti Masturzo, M.D., chief medical officer of CCS, shares how coaching those with type 1 diabetes can deliver both measurable health improvements such as significant reductions in A1C levels, and enhanced patient confidence by providing hands-on education and support. Masturzo also addressed how CCS collaborates with healthcare providers and insurers to integrate care, reduce fragmentation and improve adherence to monitoring and treatment through AI-driven efforts.
Read More
